Underuse of maintenance therapy and the over-reliance on reliever: asthma case study

A best practice approach to achieving symptom control
Dr Russell Wiseman
1
7 October 2021
Save
ClosePlease login

This content has been independently produced by ADG, made possible through sponsorship from Cipla.

Over-use of short-acting inhaled β2agonists (SABAs) is common among asthma patients. This case study highlights the problem of uncontrolled asthma and lays out a best practice approach to achieving symptom control.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .